Evidence map›Paper›PMID 24725516›Full record

ArticleAmerican journal of infection control2014

Risk factors and outcomes of infections caused by extremely drug-resistant gram-negative bacilli in patients hospitalized in intensive care units.

Sameer J Patel, André P Oliveira, Juyan Julia Zhou, Luis Alba, E Yoko Furuya, Scott A Weisenberg, Haomiao Jia, Sarah A Clock, Christine J Kubin, Stephen G Jenkins and 6 more

Abstract read
In one paragraph

Article in American journal of infection control, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. The Global Burden of Sepsis and Septic Shock.Epidemiologia (Basel, Switzerland) · 2024
    Review
  2. Article
  3. Antibiogram Profile and Detection of Resistance Genes inAntibiotics (Basel, Switzerland) · 2023
    Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Frequency ofIranian journal of basic medical sciences · 2017
    Article
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Sameer J PatelDepartment of Pediatrics, Columbia University Medical Center, New York, NY. Electronic address: sameer.patel@northwestern.edu.
André P OliveiraDepartment of Pediatrics, Columbia University Medical Center, New York, NY.
Juyan Julia ZhouDepartment of Pediatrics, Columbia University Medical Center, New York, NY.
Luis AlbaDepartment of Pediatrics, Columbia University Medical Center, New York, NY.
E Yoko FuruyaDepartment of Medicine, Columbia University Medical Center, New York, NY; Department of Infection Prevention & Control, New York-Presbyterian Hospital, New York, NY.
Scott A WeisenbergDepartment of Medicine, Alta Bates Summit Medical Center, Oakland, CA.
Haomiao JiaDepartment of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY; School of Nursing, Columbia University Medical Center, New York, NY.
Sarah A ClockDepartment of Pediatrics, Columbia University Medical Center, New York, NY.
Christine J KubinDepartment of Medicine, Columbia University Medical Center, New York, NY; Department of Pharmacy, New York-Presbyterian Hospital, New York, NY.
Stephen G JenkinsDepartment of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY.
Audrey N SchuetzDepartment of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY; Clinical Microbiology Laboratory, New York-Presbyterian Hospital, New York, NY.
Maryam BehtaClinical Performance Improvement, University of Pennsylvania Health System, Philadelphia, PA.
Phyllis Della-LattaDepartment of Pathology, Columbia University Medical Center, New York, NY.
Susan WhittierDepartment of Pathology, Columbia University Medical Center, New York, NY.
Kyu RheeDepartment of Medicine, Weill Cornell Medical College, New York, NY.
Lisa SaimanDepartment of Pediatrics, Columbia University Medical Center, New York, NY; Department of Infection Prevention & Control, New York-Presbyterian Hospital, New York, NY.

Funding

Clinical and Translational Science CenterUL1TR000457 · NCATS · WEILL MEDICAL COLL OF CORNELL UNIV · PI IMPERATO-MCGINLEY, JULIANNE L · 2012 to 2016
$46.0M
Clinical and Translational Science Center (KL2)KL2RR024997 · NCRR · WEILL MEDICAL COLL OF CORNELL UNIV · PI IMPERATO-MCGINLEY, JULIANNE L · 2007 to 2011
$1.5M
Training in Interdisciplinary Research to Reduce Antimicrobial Resistance (TIRAR)T90NR010824 · NINR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI LARSON, ELAINE LUCILLE · 2007 to 2011
$1.0M
Susceptibility Testing, Treatment Choices, and Outcomes of MDR-GNB InfectionsR01CI000537 · CI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SAIMAN, LISA · 2007 to 2009
$900k
NCATS NIH HHS UL1 TR000457NCPDCID CDC HHS R01 CI000537NCRR NIH HHS KL2 RR024997NCRR NIH HHS KL2RR024997NINR NIH HHS T90 NR010824
6 · The paper itself

Abstract

backgroundExtremely drug-resistant gram-negative bacilli (XDR-GNB) increasingly cause health care-associated infections (HAIs) in intensive care units (ICUs).

methodsA matched case-control (1:2) study was conducted from February 2007 to January 2010 in 16 ICUs. Case and control subjects had HAIs caused by GNB susceptible to ≤1 antibiotic versus ≥2 antibiotics, respectively. Logistic and Cox proportional hazards regression assessed risk factors for HAIs and predictors of mortality, respectively.

resultsOverall, 103 case and 195 control subjects were enrolled. An immunocompromised state (odds ratio [OR], 1.55; P = .047) and exposure to amikacin (OR, 13.81; P < .001), levofloxacin (OR, 2.05; P = .005), or trimethoprim-sulfamethoxazole (OR, 3.42; P = .009) were factors associated with XDR-GNB HAIs. Multiple factors in both case and control subjects significantly predicted increased mortality at different time intervals after HAI diagnosis. At 7 days, liver disease (hazard ratio [HR], 5.52), immunocompromised state (HR, 3.41), and bloodstream infection (HR, 2.55) predicted mortality; at 15 days, age (HR, 1.02 per year increase), liver disease (HR, 3.34), and immunocompromised state (HR, 2.03) predicted mortality; and, at 30 days, age (HR, 1.02 per 1-year increase), liver disease (HR, 3.34), immunocompromised state (HR, 2.03), and hospitalization in a medical ICU (HR, 1.85) predicted mortality.

conclusionHAIs caused by XDR-GNB were associated with potentially modifiable factors. Age, liver disease, and immunocompromised state, but not XDR-GNB HAIs, were associated with mortality.

Indexed as

Drug Resistance, Multiple, BacterialImmunocompromised HostAcinetobacter InfectionsAdolescentAgedAge FactorsAmikacinAnti-Bacterial AgentsCase-Control StudiesCross InfectionFemaleGram-Negative Bacterial InfectionsHospital MortalityHumansIntensive Care UnitsKlebsiella InfectionsAmikacinAnti-Bacterial AgentsLevofloxacinAntibiotic resistanceGram-negative bacteriaHealth care-associated infectionMortality

Identifiers

PMID24725516
PMCPMC4083852

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.